Prevail是一家生物技术公司,致力于为神经退行性疾病患者开发潜在的基于疾病改良AAV9的基因疗法。#生物医药下一个十年# #AAV基因治疗#查看全文
消灵通2020-12-15 22:44
$Prevail Therapeutics(PRVL)$ $礼来(LLY)$ 礼来上涨2%,Prevail Therapeutics飙涨83%;礼来宣布以8.8亿美元或每股22.5美元的价格收购Prevail Therapeutics。查看全文
牛唐2020-12-15 21:55
$礼来(LLY)$ Buy $Prevail Therapeutics(PRVL)$ for $22.50/Share in Cash ,一天一个并购,$美国生科ETF-SPDR(XBI)$ 又要嗨了查看全文
华尔街操盘手_2019-06-21 00:15
$Slack Technologies(WORK)$ $Grocery Outlet(GO)$ $Prevail Therapeutics(PRVL)$ 最全ipo上市列表 网页链接查看全文
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-034219 Size: 5 KB 网页链接
$Prevail Therapeutics(PRVL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-025274 Act: 34 Size: 6 MB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-025266 Act: 34 Size: 222 KB 网页链接
$Prevail Therapeutics(PRVL)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-20-121009 Act: 34 Size: 431 KB 网页链接
$Prevail Therapeutics(PRVL)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-20-121018 Act: 34 Size: 51 KB 网页链接
$Prevail Therapeutics(PRVL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-20-087079 Act: 33 Size: 68 KB 网页链接
$Prevail Therapeutics(PRVL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-012986 Act: 34 Size: 9 MB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-012979 Act: 34 Size: 236 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018137 Size: 5 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018118 Size: 5 KB 网页链接